Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-599-9 | CAS number: 7647-15-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1988
- Reliability:
- 1 (reliable without restriction)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 81-6 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The study was conducted prior to existance of OECD 429 (LLNA) testing guidelines
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: D. Hall, Newchurch, Staffordshire, England
- Age at study initiation: Not indicated
- Weight at study initiation: 301-374g - Route:
- intradermal and epicutaneous
- Vehicle:
- water
- Concentration / amount:
- Induction:
7.5% w/w sodium bromide, technical grade in water (intradermal injection)
30% w/w sodium bromide, technical grade in water (topical application)
Challenge:
5% and 10% w/w sodium bromide, technical grade in water - Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- Induction:
7.5% w/w sodium bromide, technical grade in water (intradermal injection)
30% w/w sodium bromide, technical grade in water (topical application)
Challenge:
5% and 10% w/w sodium bromide, technical grade in water - No. of animals per dose:
- 20 in test group
20 in control group - Details on study design:
- RANGE FINDING TESTS:
The irritancy of a range of dilutions following intradermal and topical application was investigated for the selection of suitable irritant concentrations for induction and non-irritant concentrations for challenge.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: Two
- Exposure period: day 0 intradermal injection, day 7 topical application
- Site: scapular region
- Duration: 24 h for topical application
- Concentrations: 7.5% w/w sodium bromide, technical grade in water (intradermal injection), 30% w/w sodium bromide, technical grade in water (topical application)
B. CHALLENGE EXPOSURE
- No. of exposures: One
- Day(s) of challenge: day 21
- Exposure period: 24 hours
- Site: scapular region
- Concentrations: 5% and 10% w/w sodium bromide, technical grade in water
- Evaluation (hr after challenge): 24h, 48h and 72h after challenge
OTHER:
Concentration Freunds Complete Adjuvant (FCA): 50% in water - Positive control substance(s):
- yes
- Remarks:
- Formalin
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 7.5 % / 30 %, 10 % / 5 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no clinical signs
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 7.5 % / 30 %, 10 % / 5 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no clinical signs
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no clinical signs
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no clinical signs
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 5
- No. with + reactions:
- 10
- Total no. in group:
- 20
- Remarks on result:
- positive indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 30%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no clinical signs
- Remarks on result:
- no indication of skin sensitisation
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- In this screening test performed with twenty guinea pigs, sodium bromide, technical grade did not produce evidence of delayed contact hypersensitivity. The test substance does not have to be classified and labelled with respect to skin sensitisation.
- Executive summary:
Materials and Methods
The study was designed to assess skin sensitisation potential of Sodium Bromide, technical grade. The intradermal and topical irritancy of a range of dilutions of sodium bromide, technical grade was investigated to identify (a) irritant test substance concentrations suitable for the induction phase of the main study and (b) non-irritant concentrations by the topical route of administration for the challenge phase. Based on the results of this preliminary investigation concentrations of sodium bromide for the main study were selected. For the main study twenty guinea pigs were treated with the test substance intracutaneously (day 0) and epicutaneously (day 7) for induction and epicutaneously (day 21) for challenge.
Results and Discussion
The dermal reactions seen in the test animals are similar to those seen in the control animals.
Reference
Result of pilot study:
Intradermal injection of different concentrations of sodium bromide resulted in slight to mild oedema and slight to necrotic erythema (see table 6.1.5/02-1).
Topical application of 5, 10, 20 and 30 % sodium bromide, technical grade showed localized dermal reactions in one of the animals treated with 20% of test substance. This reaction was reversible and skin appeared normal by 24 hours after treatment. All other animals did not show reactions after treatment.
Based on the results of the preliminary investigations, concentrations of 7.5% (w/w) and 30% (w/w) were selected for intradermal and topical induction and 10% and 5% (w/w) for topical challenge application.
Overall result of main study:
Sodium bromide, technical grade did not produce evidence of delayed contact hypersensitivity
Table A6.1.5/02-1 Results of pre-test with Sodium Bromide, technical grade, intradermal injection
|
||||||
Guinea-pig number |
Concentration [% w/w]
|
|
Score |
|
||
|
1 |
2 |
|
|||
4674/4679 |
10 |
D E O |
8/12 N/N 2/2 |
8/10 N/N 2/2 |
|
|
7.5 |
D E O |
8/10 2/2 1/1 |
8/10 1/1 1/1 |
|
||
5 |
D E O |
6/8 2/2 1/1 |
6/6 1/1 2/2 |
|
||
2.5 |
D E O |
6/6 2/2 1/1 |
6/6 1/1 1/1 |
|
||
1 |
D E O |
4/4 1/1 1/1 |
4/4 1/1 1/1 |
|
||
0.5 |
D E O |
4/4 1/1 1/1 |
4/4 1/1 1/1 |
|
||
0.25 |
D E O |
4/4 1/1 1/1 |
4/4 1/1 1/1 |
|
||
0.1 |
D E O |
4/4 1/1 1/1 |
4/4 1/1 1/1 |
|
||
vehicle control (water) |
D E O |
4/4 1/1 1/1 |
4/4 1/1 1/1 |
|
||
D: Diameter (mm)
E: Erythema (0-4 numerical scores)
O: Oedema (0-4 numerical scores)
N: Necrosis
1: score assessed day of injection
2: score assessed day 3 after injection
Table A6.1.5/02-2 Results of main study with Sodium Bromide, technical grade, challenge application
Treatment |
Guinea-pig number |
Erythema (E) Oedema (O) |
Score |
Results |
|||||
24 h |
48 h |
72 h |
|||||||
A |
P |
A |
P |
A |
P |
||||
Freund´s Treated control |
5590 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
5591 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5592 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5593 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5594 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5595 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5596 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5597 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5598 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5599 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5560 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5501 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5502 |
E O |
L1 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5503 |
E O |
L1 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5504 |
E O |
0 0 |
L1 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5505 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5506 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5507 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5508 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
|
5509 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
n.d. |
Test |
5510 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
5511 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5512 |
E O |
0 0 |
L1 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5513 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5514 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5515 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5516 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5517 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5518 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5519 |
E O |
0 0 |
L1 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5520 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5521 |
E O |
L1 0 |
L1 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5522 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5523 |
E O |
L1 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5524 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5525 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5526 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5527 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5528 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
|
5529 |
E O |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
- |
A Anterior site, exposed to 10% w/w sodium bromide, technical grade in distilled water
P Posterior site, exposed to 5% w/w sodium bromide, technical grade in distilled water
L1 Localized dermal reaction, restricted to a small area of the challenge site
Results: + positive
- negative
+/- inconclusive
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
Key study performed in accordance with OECD Guideline 406. 20 Dunkin-Hartley Guinea-pigs were treated with technical sodium bromide to determine skin sensitisation potential of the substance.
Topical application of 5, 10, 20 and 30 % sodium bromide, technical grade showed localized dermal reactions in one of the animals treated with 20% of test substance. This reaction was reversible and skin appeared normal by 24 hours after treatment. All other animals did not show reactions after treatment. Based on the results of the preliminary investigations, concentrations of 7.5% (w/w) and 30% (w/w) were selected for intradermal and topical induction and 10% and 5% (w/w) for topical challenge application.
Induction: A 4 cm x 6 cm area of dorsal skin on the scapular region was clipped free of hair with electric clippers. Three pairs of intradermal injectios were made simultaneously into this area. One week after the injections, the same interscapular area was clipped and shaved free of hair. A 2 cm x 4 cm patch of Whatman No.3 paper was saturated with sodium bromide, technical grade, 30% w/w in distilled water, placed on the shaved skin area and covered with impermeable plastic adhesive tape. The dressing was left in place for 48 hours.
Intradermal injection of different concentrations of sodium bromide resulted in slight to mild oedema and slight to necrotic erythema.
Animals were challenged topically two weeks after the induction period. 0.2 ml of sodium bromide, technical grade, 10 and 5% w/w in distilled water was applied to an anterior and posterior site on the flank respectively. Patches were sealed for 24 hours
For the main study twenty guinea pigs were treated with the test substance intracutaneously (day 0) and epicutaneously (day 7) for induction and epicutaneously (day 21) for challenge. Evaluations of sensitisation were made 24h, 48h and 72h after challenge. 20 Control animals were treated simultaneously without test material application. All animals were observed daily for signs of ill health of toxicity.
The dermal reactions seen in the test animals are similar to those seen in the control animals. 0/20 animals showed sensitisation reactions at any observation point. No clinical signs of toxicity were noted in any test animal during the period of the study.
Migrated from Short description of key information:
In a screening test performed with twenty guinea pigs, sodium bromide, technical grade did not produce evidence of delayed contact hypersensitivity (0/20 sensitisation rate).
Justification for classification or non-classification
Based on the experimental results of the Guinea pig maximisation test, sodium bromide is not classified for sensitization.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.